During the past decade, Kitasato University East Hospital conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 2 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Kitasato University East Hospital" #1 sponsor was "Haruhiko Fukuda" with 5 trials, followed by "Amgen" with 2 trials sponsored, "Biogen" with 1 trials sponsored, "Boston Scientific Corporation" with 1 trials sponsored and "Boston Scientific Japan K.K." with 1 trials sponsored. Other sponsors include 6 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kitasato University East Hospital" #1 collaborator was "Ministry of Health, Labour and Welfare, Japan" with 5 trials as a collaborator, "AEterna Zentaris" with 1 trials as a collaborator, "Eisai Co., Ltd." with 1 trials as a collaborator, "Japan Clinical Research Support Unit(J-CRSU)" with 1 trials as a collaborator and "Korean Cancer Study Group" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Kitasato University East Hospital" are "Gastric Cancer" (2 trials), "Lupus Erythematosus, Systemic" (2 trials), "Prostatic Neoplasms" (2 trials), "Allergic Rhinitis" (1 trials) and "Amyotrophic Lateral Sclerosis" (1 trials). Many other conditions were trialed in "Kitasato University East Hospital" in a lesser frequency.

Most popular intervention types in "Kitasato University East Hospital" are "Drug" (14 trials), "Procedure" (5 trials), "Device" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Docetaxel" (3 trials), "Apalutamide" (2 trials), "5FU+l-leucovorin" (1 trials) and "ABI-007" (1 trials). Other intervention names were less common.

The vast majority of trials in "Kitasato University East Hospital" are 16 trials for "All" genders, 4 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Kitasato University East Hospital". undefined are not yet recruiting, 3 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Kitasato University East Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Kitasato University East Hospital, 1 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".